Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NYSE:GS
NYSE:GSCapital Markets

A Look At Goldman Sachs (GS) Valuation As Iran War Spurs Growth And Inflation Concerns

Goldman Sachs Group (GS) has cut its U.S. growth forecast after the Iran war pushed oil prices higher and raised inflation risks, putting stagflation, recession odds and Fed timing squarely on investors’ radar. See our latest analysis for Goldman Sachs Group. The recent cut to Goldman Sachs’ U.S. growth forecast comes as the share price has slipped, with a 30 day share price return of an 11.01% decline and a 90 day return of an 8.08% decline, even though the 1 year total shareholder return of...
NasdaqGS:ALHC
NasdaqGS:ALHCHealthcare

Institutional Control And Insider Selling Shape Alignment Healthcare Risk Picture

Institutional investors collectively hold a large stake in Alignment Healthcare (NasdaqGS:ALHC), giving them significant influence over the company. Director Robert Scavo recently sold shares in ALHC, adding a new data point on insider sentiment. The combination of high institutional ownership and fresh insider selling is drawing attention to Alignment Healthcare's governance and shareholder alignment. Alignment Healthcare focuses on Medicare Advantage plans, targeting seniors with...
ASX:OBM
ASX:OBMMetals and Mining

A Look At Ora Banda Mining's Valuation As New Ore Sales Agreement Expands Processing Capacity

Ore Sales Agreement and what it means for Ora Banda Mining Ora Banda Mining (ASX:OBM) has moved from a non binding memorandum to a binding Ore Sales Agreement to process an additional 120,000 tonnes of surplus Davyhurst ore through third party infrastructure in March and April 2026. This enables the company to continue mining above its in house processing capacity. It also allows Ora Banda Mining to build ore stockpiles for later use in its own infrastructure, while continuing studies into a...
TSX:CM
TSX:CMBanks

Is Canadian Imperial Bank of Commerce (TSX:CM) Still Attractive After A 69% One Year Rally

If you are wondering whether Canadian Imperial Bank of Commerce is still good value after its strong run, the next sections will break down what the current share price might be implying. The stock last closed at C$132.54, with returns of 1.6% over 30 days, 5.0% year to date and 69.4% over the past year. These figures can change how you think about both upside and risk. Recent coverage has focused on Canadian Imperial Bank of Commerce as one of the large Canadian banks in a sector that many...
NasdaqCM:IGIC
NasdaqCM:IGICInsurance

How Investors May Respond To International General Insurance Holdings (IGIC) Board Refresh And New Reinsurance Expertise

International General Insurance Holdings Ltd. recently reshaped its Board, adding veteran reinsurance executive Thomas A. Collett and accepting the retirement of long-serving director David D. Anthony, while reallocating key committee roles. The appointment of Collett, with deep U.S. reinsurance market relationships, alongside refreshed committee leadership, may influence IGI’s governance and longer-term business direction. Next, we’ll examine how bringing Thomas A. Collett onto the Board...
NYSE:CCL
NYSE:CCLHospitality

Carnival Corporation (CCL) Valuation Check After Recent Share Price Pullback

Why Carnival Corporation & (CCL) is back in focus Carnival Corporation & (CCL) is drawing attention again as investors weigh a recent share price pullback against the company’s current fundamentals. These include its US$26.6b in revenue and US$2.8b in net income. See our latest analysis for Carnival Corporation &. Despite a sharp 23.95% 30 day share price return decline and a 21.86% negative share price return year to date from US$24.16, the 169.99% three year total shareholder return shows...
NYSE:CALX
NYSE:CALXCommunications

The Bull Case For Calix (CALX) Could Change Following New SmartMDU Wi‑Fi 7 Deployments - Learn Why

Calix, Inc. recently announced that Blue Stream Fiber, XMission, and Aervivo are using the Calix One platform with SmartMDU to expand secure, managed Wi‑Fi across multi-dwelling unit properties, ranging from affordable housing to luxury and mixed-use communities. This broadening ecosystem highlights how Calix’s SmartMDU and new Wi‑Fi 7 systems are becoming a turnkey infrastructure choice for property-wide connectivity and faster service activation. We’ll now examine how this expansion of...
NYSE:MPC
NYSE:MPCOil and Gas

Is Marathon Petroleum (MPC) Pricing Reflecting Its Strong Recent Share Price Performance?

If you are wondering whether Marathon Petroleum's current share price reflects its underlying value or if the market is getting ahead of itself, this article will help you frame that question clearly. With the stock at US$236.24 and returns of 4.2% over 7 days, 16.2% over 30 days, 43.1% year to date and 61.3% over 1 year, recent moves are front of mind for many investors thinking about risk and reward. Recent coverage has focused on Marathon Petroleum as part of broader discussions around US...
NYSE:COR
NYSE:CORHealthcare

A Look At Cencora (COR) Valuation After Recent Share Price Weakness

Recent performance snapshot Cencora (COR) has seen a 2.8% decline over the past day, with the share price also lower over the past week, month, and past 3 months, even as the 1 year total return remains positive. See our latest analysis for Cencora. The recent 1 day, 1 week, and 1 month share price declines suggest momentum is fading in the short term, even though the 1 year and multi year total shareholder returns remain strong. This mix of short term weakness and longer term strength can...
NasdaqGS:UTHR
NasdaqGS:UTHRBiotechs

How Investors May Respond To United Therapeutics (UTHR) IPF Trial Success And New Buyback Program

Earlier in March 2026, United Therapeutics Corporation reported full Phase 3 TETON-2 results in the New England Journal of Medicine, showing nebulized Tyvaso preserved lung function in idiopathic pulmonary fibrosis patients versus placebo and met its primary endpoint over 52 weeks. If regulators clear nebulized Tyvaso, it could become the first inhaled anti-fibrotic treatment for idiopathic pulmonary fibrosis, highlighting a potential new use for an existing pulmonary therapy alongside a...
NasdaqGS:WEN
NasdaqGS:WENHospitality

A Look At Wendy’s (WEN) Valuation After A Tough Share Price Stretch

Recent performance snapshot Wendy's (WEN) has drawn fresh attention after a tough run for the stock, with the share price at US$6.99 and negative returns over the past month, past three months and over the past year. See our latest analysis for Wendy's. The weak recent share price returns, including a 6.55% 30 day share price decline and a 51.39% 1 year total shareholder return decline, point to fading momentum as investors reassess Wendy's risk and reward profile. If you are weighing up...
NasdaqGS:COIN
NasdaqGS:COINCapital Markets

Coinbase Eyes AI Micropayment Growth As Valuation Signals Mixed Opportunity

Coinbase Global (NasdaqGS:COIN) has launched AgentKit, a toolkit that lets AI agents make verified crypto micropayments, in collaboration with World and Cloudflare. The company is also exploring a new stablecoin tailored for AI driven payment flows on Cloudflare, with a potential launch later this year. These moves extend Coinbase's role from trading venue to infrastructure provider for automated, machine to machine transactions. Coinbase Global, trading at $202.29, sits at the center of...
NasdaqGS:TRIN
NasdaqGS:TRINCapital Markets

Should Trinity Capital’s (TRIN) New Senior Debt JV and Sustained Dividends Prompt Portfolio Reassessment?

In March 2026, Trinity Capital Inc. announced that its Board declared monthly regular dividends of US$0.17 per share for April, May, and June 2026, while also forming a 50/50 joint venture with Capital Southwest Corporation to invest in first-out senior secured debt in the lower middle market. This combination of sustained monthly dividends and the new co-owned credit platform highlights Trinity’s focus on recurring income while broadening its lending footprint into senior, lower-risk...
NYSE:FLR
NYSE:FLRConstruction

A Look At Fluor (FLR) Valuation After Recent Share Price Momentum

What Fluor’s Recent Performance Tells You Fluor (FLR) has drawn investor attention after a period where the stock shows a 10.5% return over the past 3 months and a 19.4% total return over the past year. See our latest analysis for Fluor. With the share price at $45.64 and a 2.3% 7 day share price return, Fluor’s recent momentum builds on a 10.5% 3 month share price return and longer term total shareholder returns that extend over several years. If you are interested in other infrastructure...
NYSE:LUMN
NYSE:LUMNTelecom

Lumen Refreshes Leadership To Pursue Enterprise Growth And AI Transformation

Lumen Technologies (NYSE:LUMN) announced upcoming leadership and board changes, including the retirement of its Board Chair and Audit Committee Chair. General Kevin P. Chilton has been selected as the next Board Chair as part of a planned succession process. Michael Collins has been nominated to join the Board, subject to shareholder approval. The company is expanding executive roles to focus on enterprise growth and an AI led transformation. Lumen Technologies runs a large communications...
NYSE:DRD
NYSE:DRDMetals and Mining

Is DRDGOLD’s (DRD) Vision 2028 Strategy Recasting Its Risk Profile More Than Its Output?

Over the past year, DRDGOLD Limited reported lower gold production due to weaker recovery rates and weather disruptions, but still delivered higher revenue as a sharp increase in realized gold prices lifted sales by about one‑third. At the same time, DRDGOLD advanced its Vision 2028 plan by progressing the Far West Gold Recoveries Phase 2 expansion and a large solar power project, aiming to strengthen operational capacity and energy security. We’ll now examine how DRDGOLD’s Vision 2028...
NasdaqGS:ARWR
NasdaqGS:ARWRBiotechs

A Look At Arrowhead Pharmaceuticals (ARWR) Valuation As Fisher Builds Stake And SHASTA Readouts Approach

Arrowhead Pharmaceuticals (ARWR) is back in focus after Ken Fisher’s fund increased its holdings and management spotlighted upcoming Phase III SHASTA-3 and SHASTA-4 readouts for plozasiran, which has been flagged as a multibillion dollar commercial opportunity. See our latest analysis for Arrowhead Pharmaceuticals. At a share price of US$56.71, Arrowhead has had a 1 month share price return of 11.14% and a year to date share price decline of 16.34%, set against a very large 1 year total...
NasdaqGS:CROX
NasdaqGS:CROXLuxury

Assessing Crocs (CROX) Valuation After Earnings Beat And New KL Rahul Sports Campaign

Why Crocs Stock Is Back in Focus After Earnings and a New Sports Partnership Crocs (CROX) has drawn fresh investor attention after reporting a 3.2% year on year revenue decline while still beating Wall Street revenue estimates and issuing earnings guidance above expectations. At the same time, Crocs India introduced cricketer KL Rahul as brand ambassador for its new Play Hard, Rest Easy campaign, signaling a push to reach sports focused and male consumers in a key growth market. See our...
NasdaqGS:QFIN
NasdaqGS:QFINConsumer Finance

Qfin Holdings (QFIN) Margin Compression Tests Bullish Earnings Narratives

Qfin Holdings (NasdaqGS:QFIN) has released its FY 2025 numbers with fourth quarter revenue of C¥4.1b and basic EPS of C¥7.92, setting the stage for investors to reassess how the earnings story lines up with expectations. Over the past six quarters, the company has seen quarterly revenue move between C¥4.1b and C¥5.2b, while basic EPS has ranged from C¥7.92 to C¥13.41, giving you a clear view of how the top line and per share profits have tracked through different trading periods. With...
XTRA:SRT3
XTRA:SRT3Life Sciences

Sartorius (XTRA:SRT3) Valuation Check As Recent Weakness Contrasts With Rich P/E And DCF Upside

Sartorius stock performance sets the context Sartorius (XTRA:SRT3) has drawn attention after a recent 1 day move of a 2.35% decline, extending to a 1 week slip of 1.03% and a month decline of 2.52%. See our latest analysis for Sartorius. That short term weakness comes on top of a softer trend, with the 90 day share price return at a 7.24% decline and the 1 year total shareholder return at a 7.59% loss. This points to fading momentum as investors reassess growth and risk. If Sartorius’s...
NasdaqGM:SHLS
NasdaqGM:SHLSElectrical

Shoals Technologies Group (SHLS) Is Down 5.1% After Record Backlog And 39% Q4 Revenue Jump - What's Changed

In February 2026, Shoals Technologies Group reported a 39% year-over-year increase in fourth-quarter revenue, supported by stronger demand for utility-scale solar projects and a record full-year 2025 backlog and awarded orders of US$747.6 million across domestic and international markets. This combination of accelerating revenue and a historically high order book highlights how Shoals’ solar infrastructure products are being pulled through by large-scale project demand worldwide. We’ll now...
OTCPK:FREV.S
OTCPK:FREV.SREITs

First Real Estate Investment Trust Of New Jersey (OTCPK:FREV.S) Steady FFO Base Challenges Bearish Narratives

First Real Estate Investment Trust of New Jersey (FREV.S) opened Q1 2026 with total revenue of US$7.5 million and basic EPS of US$0.13, giving investors a clean read on how the new fiscal year is starting. The company has seen quarterly revenue move in a tight band around US$7.2 million to US$7.5 million since early 2024, while basic EPS has ranged from about US$0.08 to US$0.15 over that stretch. This sets a clear baseline for how earnings power has tracked alongside a largely steady top...
NYSE:VVX
NYSE:VVXAerospace & Defense

Does V2X’s Elastic Partnership Reshape Its Data-Driven Mission Solutions Story For VVX Investors?

On 16 March 2026, V2X, Inc. announced a collaboration with Elastic to integrate advanced search and analytics for government, defense, and intelligence customers, aiming to speed access to critical information while meeting strict security and compliance standards. This partnership highlights V2X’s push to deepen its role in data-enabled mission solutions by enhancing multi-source analysis, logistics support, and cyber resilience for public-sector and commercial clients. Now we will examine...
NasdaqGS:LULU
NasdaqGS:LULULuxury

A Look At Lululemon (LULU) Valuation After Mixed Q4 Beat Soft Guidance And Leadership Uncertainty

Lululemon Athletica (LULU) just reported fourth quarter and full year results, beating earnings expectations but pairing that with softer guidance and continued pressure in North America, all while leadership and board changes keep governance firmly in focus. See our latest analysis for lululemon athletica. The share price reaction around the results has been choppy, with a 1-day share price return of 3.84% and a 7-day share price return of 1.60%, set against a 90-day share price return of...